Cargando…
Modulation of imidazoline I(2) binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats
BACKGROUND AND PURPOSE: CR4056 is a novel imidazoline-2 (I(2)) ligand exhibiting potent analgesic activity in animal models of pain. In this study, we investigated the effects of CR4056 in a well-established model of postoperative pain where rats develop hyperalgesia in the injured hind paw. EXPERIM...
Autores principales: | Lanza, Marco, Ferrari, Flora, Menghetti, Ilaria, Tremolada, Dario, Caselli, Gianfranco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128066/ https://www.ncbi.nlm.nih.gov/pubmed/24758515 http://dx.doi.org/10.1111/bph.12728 |
Ejemplares similares
-
Efficacy of CR4056, a first-in-class imidazoline-2 analgesic drug, in comparison with naproxen in two rat models of osteoarthritis
por: Comi, Eleonora, et al.
Publicado: (2017) -
Modulation of NMDA receptor activity by CR4056, an imidazoline-2 receptor ligand with analgesic properties
por: Puja, Giulia, et al.
Publicado: (2022) -
Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic pain
por: Ferrari, Flora, et al.
Publicado: (2011) -
Discriminative stimulus effects of the novel imidazoline I(2) receptor ligand CR4056 in rats
por: Qiu, Yanyan, et al.
Publicado: (2014) -
I2-Imidazoline Ligand CR4056 Improves Memory, Increases ApoE Expression and Reduces BBB Leakage in 5xFAD Mice
por: Mota, Bibiana C., et al.
Publicado: (2022)